Skip to main content

Blog

You Don’t Need RIMS: Other Options Are Sufficient

For medium-sized organizations, a well-designed Regulatory Data Layer (RDL) (or some companies call as Regulatory master data) can potentially provide the capabilities that matter most from a regulatory perspective without requiring a large, monolithic enterprise RIMS implementation.

The key distinction is: you still need regulatory data and information management; you may not need a traditional RIMS as the primary application.

Why a Regulatory Data Layer can be enough?

Medium-sized companies have a smaller regulatory footprint

A large pharma company may have thousands of products, hundreds of markets, complex legal-entity structures, and enormous submission volumes.

A medium-sized organization may have Fewer products, Fewer markets, Smaller regulatory teams, Lower submission volumes, less complex organizational structures

In that environment, implementing a full enterprise RIMS can introduce substantial configuration, administration, integration, licensing, and change-management overhead.

An RDL can provide the common regulatory information foundation without necessarily replacing every existing application.

The real problem is often fragmented data – not lack of another application

Imagine regulatory information already exists across:
  • Document management
  • Quality systems
  • Submission publishing
  • SharePoint
  • Spreadsheets

Buying another large application does not automatically solve fragmentation.

Instead, an RDL can sit across these systems:

Source systems → Regulatory Data Layer → AI / Analytics / Applications

This type of approach provides a consistent representation of:

Product → Country → Authorization → Submission → Sequence → Commitment → Regulatory Event → Document

The systems remain where they are, while the RDL provides the common regulatory context.

You can avoid duplicating the systems of record

A well-designed RDL shouldn’t become another giant database where every regulatory data or document and record is copied.

Instead, it can maintain Regulatory master data, Key metadata, Relationships, References to source records, Regulatory events, Status, and Access controls

For example:
Regulatory questionRDL role
What products do we have?Product reference/master data
Where are they authorized?Authorization relationships
What submissions exist?Submission metadata
What documents support them?Document references
What commitments remain?Commitment data
Where did this information come from?Provenance
What changed?Events/history
Who can access it?Governance/access layer

This is important because the RDL becomes a layer of intelligence and context rather than another repository competing with existing systems or increasing maintenance/support costs

For a medium-sized pharma company, the question may no longer be “Which RIMS should we buy?” but “What regulatory capabilities do we actually need, and can a governed regulatory data layer connect our existing systems and AI agents to deliver them?”

The critical word is governed. Without data ownership, provenance, access control, auditability, lifecycle management, and appropriate controls around AI actions, an RDL can simply become another integration layer rather than a credible regulatory foundation.

Share the Blog :

Previous Post

Next Post

Related Posts

How AI Is Changing the Way MedTech Te…

The medical device industry moves at a rapid p…

Excel-based Regulatory Tracking vs RI…

Navigating the landscape of medical device com…

Digital RIM for Next-Gen Medical Devi…

The medical device industry is undergoing a ra…

CONNECT WITH US

    Subscribe
    The First Step

    Let's talk about how DDi can help you